SCYX FY 2016 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$257,000+0.0% YoY

Gross Profit

$257,000100.0% margin

Operating Income

-$28M-10823.7% margin

Net Income

-$30M-11668.9% margin

EPS (Diluted)

$-15.75

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$60M

Total Liabilities

$25M

Stockholders' Equity

$35M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$257,000	$257,000	+0.0%
Gross Profit	$257,000	$257,000	+0.0%
Operating Income	-$28M	-$28M	+1.9%
Net Income	-$30M	-$33M	+8.1%